Citron tweets Valeant has better chance of going to zero than Herbalife ever will
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Citron Research: Don't Expect Anything Earth-Shattering on Valeant (VRX) Come Monday
November 1, 2015 7:32 PM ESTCitron Research's Andrew Left is dialing back on what investors should expect when he updates his report on battered Valeant Pharma (NYSE: VRX) on Monday.
During Bill Ackman's 4-hour defense of Valeant on Friday, short seller Left tweeted: "$VRX has a... More
Valeant Pharma (VRX) Trades Near Lows Heading Into Weekend
October 30, 2015 3:23 PM EDTValeant Pharma (NYSE: VRX) fell to session lows in the final hour of trading. Earlier Citron said it plans to update its short report on Monday, claiming the company is "dirtier than has been reported." Concerns about the possible release of new information set... More
Citron's Left Will be on CNBC Monday to Talk About Valeant (VRX)
October 30, 2015 12:27 PM EDTCitron's Andrew Left will be back on CNBC's Halftime Report on Monday, November 2nd, to talk about his upcoming report on Valeant Pharma (NYSE: VRX).
... More